Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease have?
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease has 1,001 citations in the OpenAlex counts ScholarIQ stores.
When was Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease published?
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease has 2013 year in the ScholarIQ index.
What is the open-access status of Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease?
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease has bronze oa status in the ScholarIQ index.
What is the DOI of Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease?
The DOI for Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease is on the source record.
What is the PMID of Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease?
The PMID for Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease is on the source record.
What is the OpenAlex record for Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease?
The OpenAlex for Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease is on the source record.